Anti-Brexit Group Can't Bring No-Deal Drug Policy Challenge
(Bloomberg) -- An 11th-hour lawsuit challenging the government’s plans for drug supplies in a no-deal Brexit can’t go ahead, a London judge ruled Friday, dismissing a lawsuit that could’ve potentially triggered a race against the clock to change critical healthcare rules.
The Good Law Project -- a non-profit group that says Brexit is a “terrible idea” -- lost its bid to bring a court challenge over government plans to let pharmacists give patients alternative medications to those prescribed by their doctor in some cases, if a no-deal Brexit leads to serious drug shortages.
- Ruling by Judge Michael Supperstone came shortly before Members of Parliament voted against Prime Minister Theresa May’s Brexit deal for a third time.
- Judgment “swallows wholesale the arguments advanced by the government,” Jolyon Maugham, who runs the Good Law Project, said by email
- The group is considering an appeal, Maugham said
©2019 Bloomberg L.P.